March 2021 – Kinstellar has successfully advised Eight Roads on its sale of Optegra International Limited (“Optegra”) to H2 Equity Partners. Optegra is a leading pan-European ophthalmology group with 23 eye hospitals and clinics across the United Kingdom, the Czech Republic and Poland. The company provides a range of critical eye-care services including cataract surgeries and AMD, as well as leading innovative vision correction procedures.
Kinstellar was part of a multijurisdictional team led by McDermott Will & Emery and advised mainly on legal matters related to Lexum, the Czech subsidiary of Optegra. Lexum is an established eye-care services provider that has been active on the market for more than 25 years. The company has performed more than 500,000 procedures and currently operates five clinics across the country.
The Kinstellar team in Prague consisted of Tomáš Čihula (Partner), Adam Němec (Senior Associate), Tereza Mašková (Junior Associate), and Matěj Večeřa (Junior Associate).